UA106478C2 - Комбінація інсуліну і агоніста glp-1 - Google Patents

Комбінація інсуліну і агоніста glp-1

Info

Publication number
UA106478C2
UA106478C2 UAA201106137A UAA201106137A UA106478C2 UA 106478 C2 UA106478 C2 UA 106478C2 UA A201106137 A UAA201106137 A UA A201106137A UA A201106137 A UAA201106137 A UA A201106137A UA 106478 C2 UA106478 C2 UA 106478C2
Authority
UA
Ukraine
Prior art keywords
glp
insulin
agonist
combination
drug
Prior art date
Application number
UAA201106137A
Other languages
English (en)
Russian (ru)
Inventor
Ульрих ВЕРНЕР
Original Assignee
Санофи-Авентис Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис Дойчланд Гмбх filed Critical Санофи-Авентис Дойчланд Гмбх
Priority claimed from PCT/EP2009/063195 external-priority patent/WO2010043566A2/de
Publication of UA106478C2 publication Critical patent/UA106478C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Винахід стосується лікарського препарату, який включає Gly(A21)-Arg(B31)-Arg(B32) інсулін людини і desРrоексендин-4(1-39)-(Lys)-NH.
UAA201106137A 2008-10-17 2009-10-09 Комбінація інсуліну і агоніста glp-1 UA106478C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008051834A DE102008051834A1 (de) 2008-10-17 2008-10-17 Kombination von einem Insulin und einem GLP-1-Agonisten
PCT/EP2009/063195 WO2010043566A2 (de) 2008-10-17 2009-10-09 Kombination von einem insulin und einem glp-1-agonisten

Publications (1)

Publication Number Publication Date
UA106478C2 true UA106478C2 (uk) 2014-09-10

Family

ID=42034871

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201106137A UA106478C2 (uk) 2008-10-17 2009-10-09 Комбінація інсуліну і агоніста glp-1

Country Status (2)

Country Link
DE (1) DE102008051834A1 (uk)
UA (1) UA106478C2 (uk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011058082A1 (de) * 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
BR112014004726A2 (pt) * 2011-08-29 2017-04-04 Sanofi Aventis Deutschland combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (da) 1988-05-11 1988-05-11 Novo Industri As Nye peptider
DE3837825A1 (de) 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
KR910700262A (ko) 1988-12-23 1991-03-14 안네 제케르 사람 인슐린 유사체
NZ232375A (en) 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
DK155690D0 (da) 1990-06-28 1990-06-28 Novo Nordisk As Nye peptider
US5424286A (en) 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
ES2359031T3 (es) 1996-08-08 2011-05-17 Amylin Pharmaceuticals, Inc. Composición farmacéutica que comprende un péptido de exendina-4.
DE122009000079I2 (de) 1996-08-30 2011-06-16 Novo Nordisk As Novo Alle Glp-1 derivate
JP4798814B2 (ja) 1997-01-07 2011-10-19 アミリン・ファーマシューティカルズ，インコーポレイテッド 食物摂取低減用のエキセンジンおよびそのアゴニストの使用
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DK1019077T4 (da) 1997-08-08 2011-03-07 Amylin Pharmaceuticals Inc Hidtil ukendte exendinagonistforbindelser
ATE381939T1 (de) 1997-11-14 2008-01-15 Amylin Pharmaceuticals Inc Neuartige exendin agonisten
DK1032587T4 (da) 1997-11-14 2013-04-08 Amylin Pharmaceuticals Llc Hidtil ukendte exendinagonist-forbindelser
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
WO2004005342A1 (en) 2002-07-04 2004-01-15 Zealand Pharma A/S Glp-1 and methods for treating diabetes
PL377591A1 (pl) 2002-10-02 2006-02-06 Zealand Pharma A/S Stabilizowane związki eksendyny-4
DE102008003568A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008003566A1 (de) 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil

Also Published As

Publication number Publication date
DE102008051834A1 (de) 2010-04-22

Similar Documents

Publication Publication Date Title
TN2011000160A1 (en) Combination of an insulin and a glp -1 agonist
TN2012000216A1 (en) Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
EP2047252A4 (en) STRUCTURE OF THE INSULIN RECEPTOR ECTODOMAINE
EP2253348A4 (en) DEVICE FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
PT2307079E (pt) Dispositivo de administração de medicamentos
HK1153156A1 (en) Medication delivery device
SI2274029T1 (sl) Naprava za dovajanje zdravila
IL208966A0 (en) Medication delivery device
IL218919A0 (en) Drug delivery device with clearance compensation means
ZA201006518B (en) Drug delivery system with stabilising effect
IL212603A0 (en) Combined drug administration
UA106478C2 (uk) Комбінація інсуліну і агоніста glp-1
MY161655A (en) Unit dosage of apadenoson
GB0809760D0 (en) Transdermal drug delivery wristband